Introduction

Amniograft is a cost effective biocompatible wound dressing material, which is repared by chemically modifying the human amniotic membrane by using suitable cross linker and subsequently drying the resulting product followed by sterilisation. The product, identified as Amniograft, has enormous application for the purpose of management of wounds of various nature. Since it is a homograft while using for human wound dressing, the compatibility of the product is much more compared to that of the conventional materials, which are usually made from the bovine source.

Industry classification

Primary : Hospital waste
Secondary : Drug / pharmaceutical industry
Product type : Commercial

Manufacturing

a) process used

Primary : Biochemical processing
Secondary : Sterilisation and sheet casting

b) Major machinery used : Shaking / totation assembly, Sterilisation chamber

Status : Yet to be Licensed

Economic Information

Minimum Economic size: 1000 sheets per month (size 500 cm2)
Optimum Investment : Rs.10 lakhs (approx.)

Major Raw Materials Required : Human amniotic membrane

Patent Information

If Patented : Indian patent applied for
Patent No. : Appl. No.10D3194
Country : India
Date granted : Patent Pending

Contact for more information:

Dr. T. Ramasami,
Director, Central Leather Research Institute (CLRI),
Chennai -600 020, India
Tel: +91-(0)44-4910846
Fax: +91-(0)44-4912150
Email: clrimd@md2.vsnl.net.in